Chimerix, a developer of antiviral therapeutics, is expanding its management team with the addition of a chief financial officer.

Timothy Trost, who had been working with the company as an advisor, is taking the position, joining the company from Argos Therapeutics where he also was CFO. Trost has also served as CFO at InteCardia, which focuses on cardiac imaging.

Trost helped Chimerix in its latest round of venture capital fund raising.

Get the latest news alerts: Follow WRAL Tech Wire at Twitter.